4 -1 (21) 2018 — Rasulova Z.D, Daminova M.N., — THE USAGE OF PROBIOTICS ENTEROL IN COMBINED THERAPY OF COLON MICROBIOCENOSIS IN CHILDREN WITH TYPE I DIABETES MELLITUS

THE USAGE OF PROBIOTICS ENTEROL IN COMBINED THERAPY OF COLON MICROBIOCENOSIS IN CHILDREN WITH TYPE I DIABETES MELLITUS

Rasulova Z.D, Tashkent Pediatric Medical Institute, Tashkent Medical Academy.

Daminova M.N., Tashkent Pediatric Medical Institute, Tashkent Medical Academy.

Abdullaeva O.I., Tashkent Pediatric Medical Institute, Tashkent Medical Academy.

Daminova Kh.M, Tashkent Pediatric Medical Institute, Tashkent Medical Academy.

Resume,

The article presents the results of studying the efficacy of probiotic enterol in the complex therapy of patients with intestinal microbiocenosistype 1 diabetes mellitus. To accomplish the results of clinical and bacteriological examination of 33 children with type 1 diabetes, aged 10 to 18 years. The analysis of the effectiveness of probiotic enterol in the complex therapy of patients with intestinal microbiocenosis type 1 diabetes. The control group consisted of 30 healthy individuals. Conducts bacteriological analysis of the intestinal microflora. All of the surveyed children with type 1 diabetes, in the intestinal microflora are disbiotic changes. The results indicate the feasibility of active correction dysbiotic changes in diabetes mellitus type 1 enzyme preparations such as enterol.

Keywords: probiotic enterol, type 1 diabetes mellitus, intestinal microbiocenosis.

First page

15

Last page

17

For citation: Rasulova Z.D, Daminova M.N., Abdullaeva O.I., Daminova Kh.M, The usage of probiotics enterol in combined therapy of colon microbiocenosis in children with type i diabetes mellitus //New Day in Medicine 1(21)2018 15-17 https://cutt.ly/Ineqmc4

List of References

1. Авдеев В.Г. Диабетическая энтеропатия //Фарматека – №3 – 2010 – с. 46-49.
2. Даминова М.Н., Ахмедова 0.У., Абдуллаева О.И. ^аруше^ия работы тожого кишечжка у детей больных сахарным диа­бетом типа 1. //IV Кошресс Евро-Азиатского общества по и^фекцио^^ым болез^ям.-18-20 мая 2016 года Сажт-Петер- бург.- Россия.- Жур^ал И^фектологии.-Том 8.-№2.-С.38-39.
3. Дедов И.И., Мельниченко Г.А., Фадеев В.В. Эвдокрижлогия: /’Учебник. -М.:Медици^а, 2000.-с.494-500.
4. Дорофеев А.Э. Заболевания кишечника.- /Горловка: Ёкдтар, 2010.- 532 с.
5. Касатки^а Э.П., Воро^и^ А.А., Тара^е^ко Ё.А. Бактериоло­гическая диашостика дисбактериоза кишечника у детей, боль- жзх сахарным диабетом //Метод. рек. М 1996.
6. Stanghellini V, Tosetti C, Paternico A, et al. Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. //Gastroenterology 1996; 110: 1036-42.
7. Brugman S., Klatter F. A., Visser J. T. et al. Antibiotic treatment partially protects against type 1 diabetes in the bio-breeding diabetes-prone rat: is the gut flora involved in the development of type 1 diabetes? //Diabetologia. 2006, Sep; 49 (9): 2105-2108.
8. Kotowska M., Albrecht P., Szajewska H. Saccharomyces boulardii in the prevention of antibion of antibiotic associated diarrhea in children: randomized double – blind placebo- controlled trial / /Aliment Pharmacol Ther.2005. Mar 1; 21(5); 583-90.